1. Epizyme, Inc.

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. Fate Therapeutics Announces the Appointment of Dr. Shefali Agarwal to its Board of Directors

      Fate Therapeutics Announces the Appointment of Dr. Shefali Agarwal to its Board of Directors
      SAN DIEGO, July 17, 2019 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that Dr. Shefali Agarwal has been appointed to the Companys Board of Directors. Dr. Agarwal is currently the Chief Medical Officer of Epizyme, Inc...
      Read Full Article
    3. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content